Learn Before
Differences in 28-day mortality of severe COVID-19 patients treated with unfractionated heparin or low molecular weight heparin (LMWH) compared to control group given no anticoagulant based on SIC score
Differences in 28-day mortality of severe COVID-19 patients by D-dimer level among those given unfractionated heparin or low molecular weight heparin (LMWH) compared to control group given no anticoagulant.
Table 4. from Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [outcome differences by heparin treatment, SIC score, D-dimer levels]
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Table 4. from Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [outcome differences by heparin treatment, SIC score, D-dimer levels]
Table 4. from Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [outcome differences by heparin treatment, SIC score, D-dimer levels]